Exhibit 31.1
                                  CERTIFICATION

I, ANGELO CHINNICI, CERTIFY THE FOLLOWING:

1.            I have reviewed this quarterly report on Form 10-QSB of Amazon
              Biotech, Inc.;

2.            Based on my knowledge, this quarterly report does not contain any
              untrue statement of a material fact or omit to state a material
              fact necessary to make the statements made, in light of the
              circumstances under which such statements were made, not
              misleading with respect to the period covered by this quarterly
              report;

3.            Based on my knowledge, the financial statements, and other
              financial information included in this quarterly report, fairly
              present in all material respects the financial condition, results
              of operations and cash flows of Amazon Biotech, Inc. as of, and
              for, the periods presented in this quarterly report;

4.            Amazon Biotech, Inc.'s other certifying officer and I are
              responsible for establishing and maintaining disclosure controls
              and procedures (as defined in Exchange Act Rules 13a-14 and
              15d-14) for Amazon Biotech, Inc. and we have done the following:

a.            designed such disclosure controls and procedures to ensure that
              material information relating to Amazon Biotech, Inc. is made
              known to us by others within the Company, particularly during the
              period in which this quarterly report is being prepared;

b.            evaluated the effectiveness of Amazon Biotech, Inc.'s disclosure
              controls and procedures as of a date within 90 days prior to the
              filing date of this quarterly report (the "Evaluation Date"); and

c.            presented in this quarterly report our conclusions about the
              effectiveness of the disclosure controls and procedures based on
              our evaluation as of the Evaluation Date;

5.            Amazon Biotech, Inc.'s other certifying officer and I have
              disclosed, based on our most recent evaluation, to Amazon Biotech,
              Inc.'s auditors and the audit committee of Amazon Biotech Inc.'s
              board of directors:

a.            all significant deficiencies in the design or operation of
              internal controls which could adversely affect Amazon Biotech,
              Inc.'s ability to record, process, summarize and report financial
              data and have identified for Amazon Biotech, Inc.'s auditors any
              material weaknesses in internal controls; and

b.            any fraud, whether or not material, that involves management or
              other employees who have a significant role in Amazon Biotech,
              Inc.'s internal controls; and

6.            Amazon Biotech, Inc.'s other certifying officer and I have
              indicated in this quarterly report whether or not there were
              significant changes in internal controls or in other factors that
              could significantly affect internal controls subsequent to the
              date of our most recent evaluation, including any corrective
              actions with regard to significant deficiencies and material
              weaknesses.


March 17, 2005                                 /s/ Angelo Chinnici, M.D.
                                               ---------------------------------
                                                   Angelo Chinnici, M.D.
                                                   Chief Executive Officer
                                                   (Principal Executive Officer)